Tandutinib in Treating Patients Who Have Undergone Surgery for Metastatic Kidney Cancer

Clinical trial NCT00408902 · COMPLETED

Trial details

NCT number: NCT00408902
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Clear Cell Renal Cell Carcinoma Recurrent Renal Cell Cancer Stage IV Renal Cell Cancer

Start date: 2006-11-01
Primary completion: 2008-10-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.